doi: 10.21037/qims-2024-2918 Summary Keywords AI diagnostics, biomarkers, exocrine pancreatic insufficiency, pancreatogenic diabetes, precision medicine, reclassification, pancreatogenic diabetes mellitus Citation Rangraze IR, El-Tanani M, Wali AF, Babiker R, Rabbani SA, Matalka II, Satyam SM, Avagimyan A, Hoffmann K, Ilias I, Ispas S, Viviana M, Paczkowska A and Rizzo M (2026) Redefining pancreatogenic diabetes mellitus through molecular, imaging, and AI-driven evidence
Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L-carnitine supplementation
What is transactional analysis therapy
The KPV + BPC-157 + LL-37 Capsule Stack For those who prefer oral delivery, the KPV + BPC-157 + LL-37 capsule stack is the clinic's advanced oral peptide formulation designed to support gut healing, inflammation control and immune defence in one
Ribolsi, M., Daskalakis, Z
However, they are not without risks, and potential side effects should be considered